Celeventus

We have a new method to dry vaccines and other biologically sensitive substances with preserved
activity. Our mission is to help more humans get essential vaccines through improved manufacturing technology.

Target group
PhD students, Researchers, postdocs are all relevant. Scope adjusted based on applicant.

About the company
Celeventus AB helps develop thermostable vaccines using a new scalable & gentle process to dry
sensitive biologically active substances in room temperature.

The project
We are collaborating with world-renowned vaccine researcher Professor Jan Holmgren and his team at the University of Gothenburg to test our innovative drying technology for vaccine production.
Professor Holmgren, known for developing the first cholera vaccine, is leading efforts to create a
thermostable capsule form of the oral cholera vaccine using freeze-drying. This method is now being compared with Celeventus' fast-air nebulizer-based spray-drying method, demonstrating that our method can be a viable alternative and opens the door to drying even more sensitive vaccines where freeze-drying is too harsh. Early results (Oct 15, 2024) from drying with the Celeventus method arepromising, and further joint experiments are planned for 2025.

Location will be at the company's office in Sundbyberg and at a laboratory at Gothenburg University.

The candidate
Relevant backgrounds:
● Microbiologists with experience in vaccine development and testing, particularly with
cholera vaccines.
● Biochemists specializing in protein stability and formulation, as preserving the biological
activity of the vaccine is crucial.
● Pharmaceutical scientists with expertise in drug delivery systems, especially those focused
on oral or pulmonary delivery, as the dry powder vaccine may have novel administration
routes.
● Chemical engineers with knowledge of spray drying and particle engineering, to optimize the
drying process and particle size distribution.

Contact information
Name: Johan Acevedo
Email: johan@celeventus.com
Telephone: +46 (0) 73 697 5200
Company website: www.celeventus.co